國家衛生研究院 NHRI:Item 3990099045/13103
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907913      Online Users : 885
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/13103


    Title: A supramolecular bait to trigger non-equilibrium co-assembly and clearance of ABeta42
    Other Titles: A supramolecular bait to trigger non-equilibrium co-assembly and clearance of Aβ42
    Authors: Wu, TH;Lai, RH;Yao, CN;Juang, JL;Lin, SY
    Contributors: Institute of Biomedical Engineering and Nanomedicine;Institute of Molecular and Genomic Medicine
    Abstract: In the living systems, the non-equilibrium states that control the assembly-disassembly of cellular components underlie the gradual complexification of life, whereas in the nonliving systems, most molecules follow the laws of thermodynamic equilibrium to sustain dynamic consistency. However, very little is known about the roles of non-equilibrium states of interactions between supramolecules in living systems. Here, we identified a non-equilibrium state of interaction between supramolecular lipopolysaccharide (LPS) and Aβ42, an aggregate-prone protein that causes Alzheimer's disease (AD). Structurally, the polymerized propagation of Aβ42 presents a specific groove that is recognized by the amphiphilicity of LPS bait in a non-equilibrium manner. Functionally, the transient complex elicits a cellular response to clear extracellular Aβ42 deposits via an endolysosomal mechanism in neuronal cells. Since the impaired clearance of toxic Aβ42 deposits correlates with AD pathology, the non-equilibrium interaction between LPS and Aβ42 could represent a useful target for the development of AD therapeutics.
    Date: 2021-02
    Relation: Angewandte Chemie. 2021 Feb;60(8):4014-4017.
    Link to: http://dx.doi.org/10.1002/anie.202013754
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1433-7851&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000602541200001
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85097604829
    Appears in Collections:[Shu-Yi Lin] Periodical Articles
    [Jyh-Lyh Juang] Periodical Articles
    [Rai-Hua Lai] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    PUB33191624.pdf1085KbAdobe PDF299View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback